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Feasibility of a home-based exercise 
intervention with remote guidance 
for patients with stable grade II 
and III gliomas: a pilot randomized 
controlled trial
Karin Gehring1,2, Corelien JJ Kloek1,3, Neil K Aaronson4, 
Kasper W Janssen5, Lee W Jones6, Margriet M Sitskoorn1 
and Martijn M Stuiver7,8
Abstract
Objective: In this pilot study, we investigated the feasibility of a home-based, remotely guided exercise 
intervention for patients with gliomas.
Design: Pilot randomized controlled trial (RCT) with randomization (2:1) to exercise or control group.
Subjects: Patients with stable grade II and III gliomas.
Intervention: The six-month intervention included three home-based exercise sessions per week at 
60%–85% of maximum heart rate. Participants wore heart rate monitors connected to an online platform 
to record activities that were monitored weekly by the physiotherapist.
Main measures: Accrual, attrition, adherence, safety, satisfaction, patient-reported physical activity, 
VO2 peak (by maximal cardiopulmonary exercise testing) and body mass index (BMI) at baseline and at 
six-month follow-up.
Results: In all, 34 of 136 eligible patients (25%) were randomized to exercise training (N = 23) or 
the control group (N = 11), of whom 19 and 9, respectively, underwent follow-up. Mean adherence 
to prescribed sessions was 79%. Patients’ experiences were positive. There were no adverse events. 
Compared to the control group, the exercise group showed larger improvements in absolute VO2 peak 
(+158.9 mL/min; 95% CI: −44.8 to 362.5) and BMI (−0.3 kg/m²; 95% CI: −0.9 to 0.2). The median increase 
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in physical activity was 1489 metabolic equivalent of task (MET) minutes higher in the exercise group. The 
most reported reasons for non-participation were lack of motivation or time.
Conclusion: This innovative and intensive home-based exercise intervention was feasible in a small 
subset of patients with stable gliomas who were interested in exercising. The observed effects suggest 
that the programme may improve cardiorespiratory fitness. These results support the need for large-scale 
trials of exercise interventions in brain tumour patients.
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Introduction
After treatment with surgery, radiotherapy and/or 
chemotherapy, patients with gliomas with favour-
able prognosis may live free from severe neuro-
logical symptoms for years until the disease 
progresses. During this period of time, many 
patients may suffer from a wide range of physical, 
psychological/emotional and cognitive symptoms.1 
Few efforts have been undertaken to address these 
problems, despite the relatively young age and 
favourable prognosis of this clinical population.
Recently, Cormie et al.2 concluded, based on the 
evidence for beneficial effects of exercise in man-
aging physical, psychological and cognitive symp-
toms in other populations, that exercise may be a 
promising intervention to aid in the management of 
the multitude of brain cancer symptoms and treat-
ment side-effects. However, there has been very 
limited research on the feasibility and effectiveness 
of exercise interventions in patients with brain 
tumours. Feasibility may be a particular concern in 
this population, as neuro-oncological symptoms 
may limit patients’ willingness and ability to par-
ticipate in an exercise intervention (study).
To date, two small, uncontrolled (pilot) exer-
cise intervention studies (respectively, n = 8 and 
14 at follow-up) have been conducted in this pop-
ulation, the results of which suggest that an exer-
cise programme is both feasible and safe.2,3 In a 
study on exercise preferences of 106 patients with 
brain tumours (50% glioma), the majority of the 
respondents were interested in physical exercise 
and felt that they would be able to do exercise.4 
Glioma patients also reported a strong preference 
for home-based exercise programmes.4,5 Home-
based interventions may be particularly important 
for brain cancer patients, as neurological symp-
toms such as epilepsy can restrict patients’ 
mobility (i.e. the ability to drive or use public 
transportation).4
Recently, we developed and pilot-tested a novel 
home-based aerobic exercise intervention for 
patients with stable, lower-grade glioma. The ulti-
mate aim of the programme was to maintain or 
improve cognitive function through improvement 
of aerobic fitness.6–8
The primary purpose of this article is to present 
a detailed evaluation of the six-month exercise 
intervention in terms of accrual, attrition, adher-
ence, safety and patient satisfaction in a research 
setting. These results may help to design future 
studies on the benefits of exercise in brain tumour 
patients. In addition, we describe the direct effects 
of the programme on cardiorespiratory fitness 
(VO2 peak) and self-reported physical activity, as 
we consider these intermediate endpoints as a 
measure of feasibility of an exercise programme 
designed to improve cognitive function. Detailed 
findings with respect to cognitive performance and 
patient-reported outcomes will be reported in a 
subsequent paper.
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Methods
Study design
Ethical approval was obtained from the medical 
ethics committee (METC) Brabant, Tilburg, The 
Netherlands (N44024.008.13). The trial was regis-
tered with www.clinicaltrials.gov: NCT02303938. 
Enrolment started in September 2013 and ended in 
December 2014.
In this pilot, randomized controlled study 
(RCT), patients were allocated to a six-month exer-
cise intervention and a waiting-list control group.
Participants
We recruited patients from three Dutch hospitals: 
Elisabeth-TweeSteden Hospital Tilburg, Haaglanden 
Medical Center The Hague and Erasmus Medical 
Center Rotterdam. Eligibility criteria were as fol-
lows: histologically proven or presumed (on the 
basis of clinical and magnetic resonance imaging 
(MRI) data) diffuse, low-grade (i.e. World Health 
Organization (WHO) grade II) glioma, or anaplastic 
glioma (WHO grade III); clinically stable for a mini-
mum of six months prior to study entry as deter-
mined by MRI; current self-reported inactivity or 
only a moderate level of physical activity (i.e. 
<20 minutes of vigorous exercise on at least three 
days of the week) as assessed with the Physician-
based Assessment and Counseling for Exercise 
(PACE);9 access to the Internet; basic fluency in the 
Dutch language; interest in undergoing the physical 
exercise programme under investigation; and, finally, 
a VO2 peak, as assessed with maximal cardiopulmo-
nary exercise test, within the range of sedentary or 
recreationally active reference groups,10 allowing 
room for further improvement of fitness.
Exclusion criteria were as follows: antitumour 
treatment (i.e. surgery, radiotherapy, chemotherapy, 
corticosteroids) within six months prior to study 
entry; use of beta-blockers;11 psychiatric or severe 
cognitive problems that would preclude programme 
participation; serious orthopaedic conditions, motor 
deficits, cardiovascular, cardiopulmonary or neuro-
logical condition; or contra-indications for exercise 
without face-to face supervision as assessed with 
the Physical Activity Readiness Questionnaire 
(PAR-Q),12 or as judged by the sports physician 
based on the cardiopulmonary exercise test; and no 
room for cognitive improvement, as assessed with 
neuropsychological testing.
Recruitment procedure
Potential participants underwent three screening 
phases. In the first screening phase, we identified 
potentially eligible patients via pathology data-
bases or direct referral from the participating hos-
pitals. Medically eligible patients received a study 
information letter from their physician and a reply 
card on which they could indicate whether they 
gave permission to be approached by phone. 
Interested patients were in this second phase called 
by a member of the research team who explained 
the study purpose and procedures, and screened 
for initial eligibility. In the third phase, all indi-
vidual eligible patients provided informed con-
sent, underwent neuropsychological testing and 
completed self-report questionnaires on cognitive 
symptoms, fatigue, sleep, mood and quality life at 
home. Subsequently, they were invited to undergo 
a maximal cardiopulmonary exercise test in a 
sports medical centre.
Eligible patients were randomly allocated in a 
2:1 ratio to an exercise group or a waiting-list con-
trol group. A minimization procedure13 was used to 
ensure that the two groups were balanced on age 
(<40, 40–50, >50), education (lower vs. higher), 
WHO tumour grade (II vs. III), disease duration 
(<five vs. ≥five years), relative VO2 classification 
according to reference groups (recreational physi-
cal activity vs. sedentary10) and performance on the 
letter digit substitution task14 (≤43 vs. >43). 
Allocation concealment was ensured using an 
online computer software program.15 All patients 
were informed about their allocation by phone. 
Besides the sports physicians who administered the 
exercise tests, the other assessors, nor the patients, 
could be blinded to group allocation.
The decision to halt participation in case of 
progressive disease during the course of the study 
depended on further treatment and/or was left up 
to the individual patient and his or her treating 
physician.
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Exercise group
The intervention comprised three home-based aero-
bic training sessions per week, for a duration of six 
months. At the start of the intervention, a physio-
therapist visited participants at home. Patients 
received an individualized exercise prescription, 
based on their level of aerobic fitness, to exercise at 
60%–85% of their maximum heart rate (see 
Appendix for a more elaborate description and 
build-up of the activities). They could choose one or 
more central activities, as long as these could meet 
the prescribed exercise intensity. The physiothera-
pist instructed patients in how to use a sports watch 
with a heart rate monitor,16 and how to upload train-
ing data at least once a week. During the activities, 
this watch provided immediate feedback about heart 
rate and, if applicable, speed and distance. Patients 
kept a log of their training experiences. The physio-
therapist monitored the training data on the platform 
on a weekly basis and provided additional personal 
feedback by e-mail. In case of motivational prob-
lems, fatigue, injury or technical problems, more 
frequent e-mail/phone contact was allowed. After 
the final exercise test, participants were called a last 
time to discuss the programme and exercise test 
results and to discuss continuation of physical exer-
cise after the study period.
Waiting-list control group
Patients in the waiting-list control group were 
advised to maintain an active lifestyle, in accordance 
with Dutch public health guidelines,17 which were 
described in two motivational brochures. Patients in 
this group also received bi-monthly phone calls from 
the research assistant during which general questions 
about their health were asked. These calls were 
intended to provide some control for potential effects 
due to the attention that was given to the exercise 
group. After all assessments had been completed, 
participants in the control group were offered a train-
ing watch and a general exercise prescription.
Outcome measures
Baseline assessments of physical fitness, patient-
reported outcomes and cognitive function were 
conducted before randomization (T0) and follow-up 
assessments at six months, after patients in the exer-
cise group had completed their training (T1).
Sociodemographic and clinical information. Patients’ 
age, sex and level of education were obtained via 
interview at baseline. Clinical information, includ-
ing date of diagnosis and tumour characteristics, 
such as site, and histology, and anticancer and anti-
epileptic treatment was abstracted from the medi-
cal records.
Feasibility parameters. Accrual was defined as the 
percentage of eligible patients who entered into the 
study. Attrition was defined as the percentage of 
randomized patients who dropped out of the study. 
Reasons for non-participation and discontinuation 
were recorded.
Individual exercise data on type of sport, dura-
tion of intervention, attended training days, mean 
session duration (minutes) and mean intensity (% 
of maximum heart rate) were extracted from the 
patients’ accounts on the online platform. 
Adherence was then calculated as the percentage of 
the physical exercise sessions completed out of 
prescribed sessions in the period in which a patient 
participated in the programme; ≥75% was consid-
ered sufficient. Average intensity was indicated by 
the average heart rate of all training sessions as a 
percentage of the maximum heart rate as measured 
during the first exercise test; a percentage of 60%–
85% was considered sufficient.
Finally, two physiotherapists (C.J.J.K. and 
M.S.) independently rated overall exercise per-
formance for each participant as A (excellent/
good), B (adequate) or C (inadequate), based on 
observed adherence, session duration and inten-
sity. Disagreements were resolved by consensus. 
Injuries or side-effects attributable to the exercise 
intervention were reported in the physiothera-
pists’ logbook.
Patients’ satisfaction. Patients’ satisfaction with the 
programme was assessed in the exercise group 
with a post-training, study-specific questionnaire. 
Qualitative data from patients’ e-mails to the physi-
otherapist were collected.
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Self-reported physical activity. Self-reported level of 
physical activity was assessed by calculating meta-
bolic equivalent of task (MET) minutes/week 
acquired during walking, moderate or vigorous 
physical activity, as self-reported on the Interna-
tional Physical Activity Questionnaire (IPAQ).18,19
Physical outcomes. Physical fitness was assessed at 
baseline (T0) and after six months (T1) in both 
study groups with a maximal cardiopulmonary 
exercise test on a cycle ergometer with electrocar-
diogram (ECG) and breathing gas analysis. The 
purpose of the test in this study was threefold: (1) 
safety testing and screening, (2) baseline assess-
ment for use in individualizing exercise prescrip-
tion and (3) (outcome) assessment of VO2 peak.
The exercise test was performed in one of the 
four participating Sports Medical Centers affiliated 
with the patient’s hospital. These tests were super-
vised by different sports physicians, who followed a 
protocol based on the American College of Sports 
Medicine (ACSM) guidelines,20 and who were 
blinded to allocation. Raw output data of the exer-
cise test were used to extract absolute VO2 peak 
data and calculate relative VO2 peak (absolute VO2 
peak divided by body weight).
Neuropsychological assessments. Cognitive func-
tioning was assessed at the patients’ home by a 
battery of neuropsychological tests of attention, 
memory and executive function.21 Patients were 
also given several questionnaires on self-reported 
cognitive symptoms, fatigue, sleep, mood and 
quality life to be completed and returned by mail. 
For the purpose of this article, only the feasibility 
of administration of these assessments in this pilot 
study was evaluated.
Statistical methods
Based on historical patient census data from the 
three participating centres, we expected to be able 
to include 60 patients in the study. Due to the lack 
of preliminary data on the effect of exercise on 
cognitive function in glioma patients, there was no 
meaningful way to perform sample size calcula-
tions for this pilot feasibility study.
Baseline demographics, clinical and physical 
data were compared between the study groups, and 
between dropouts and patients who completed fol-
low-up. Statistical analyses were conducted for 
group outcomes on absolute and relative VO2 peak, 
body mass index (BMI), weight and patient-
reported physical activity. Absolute VO2 peak was 
used as the primary outcome for analysis of 
changes in physical fitness. No a priori level of sta-
tistical significance was set, as the objective of the 
study was not to test hypotheses, but to estimate 
potential effect sizes. Ninety-five per cent confi-
dence intervals were calculated, along with two-
sided P-values, for all comparisons.
First, we performed an intention-to-treat analy-
sis to estimate the within-group changes in physi-
cal fitness, BMI, body weight and physical activity 
using paired-samples t-tests. If test assumptions 
were violated, a Wilcoxon signed-rank test was 
used, and a 95% confidence interval for the median 
change was estimated via 1000 bootstraps.
In addition, to estimate the change specifically 
attributable to the intervention, we used linear regres-
sion analyses to compare the outcomes of both 
groups noted above at six months, controlling for 
baseline scores. Adjusted mean between-group dif-
ferences are reported with a 95% confidence interval. 
In case of violated assumptions for these tests, a 
Mann–Whitney U-test (inevitably without correction 
for baseline score) was used, and presented with 
bootstrap 95% confidence intervals for the difference 
between the group medians. Cohen’s22 d effect sizes 
were calculated for between-group effects, for which 
0.2 is considered a ‘small’ effect, 0.5 a ‘medium’ 
effect and 0.8 and larger a ‘large’ effect.
SPSS version 22.0 was used for all statistical 
analyses,23 except the calculation of 95% confi-
dence intervals for the difference between group 
medians, which was done in R 3.3.1.24
Results
Accrual and attrition
After the three phases of screening, 34 of 136 invited 
patients (25%) were recruited and allocated to the 
intervention (N = 23) or the control (N = 11) group. 
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Due to personnel and time (i.e. financial) constraints, 
we could not prolong the recruitment phase of the 
study, or include an additional participating centre, to 
recruit the projected 60 participants. Figure 1 displays 
the detailed information on recruitment and retention. 
In all, 30 (22%) patients who did not participate did 
not provide a reason for declining, did not respond 
to the invitation or could not be reached by phone. 
Of the 62 patients for whom a reason for non- 
participation was known, the most reported reasons 
were lack of motivation or time to exercise. In all, 10 
patients (16%) reported being physically unable to 
undergo intensive training or assessments. Of the 70 
patients who were screened by telephone and were 
interested in participating, 14 (20%) already met the 
criteria for a physically active lifestyle based on the 
PACE questionnaire. One patient withdrew after the 
baseline exercise test, but before randomization, 
when she understood that the programme did not 
include face-to-face training with a physiotherapist.
At baseline, 29 patients (85%) had a VO2 peak 
comparable to sedentary age-matched healthy con-
trols and 5 (15%) comparable to people involved in 
recreational sports.10 Except for a higher proportion 
of grade II tumours in the exercise group, the groups 
were comparable at baseline with respect to soci-
odemographic, clinical or physical characteristics 
(Table 1).
No differences were observed in baseline soci-
odemographic, clinical and physical characteristics 
between dropouts (N = 6) and patients who com-
pleted follow-up measurement (N = 28), except that 
patients with grade III gliomas were more likely to 
drop out. One patient who learned during the inter-
vention that he had progressive disease was able to 
undergo the follow-up exercise test.
Exercise programme data: exercise 
preferences and adherence
A detailed overview of training variables per case in 
the exercise group is presented in the Online table. 
Most patients (n = 15 of 23) chose a combination of 
activities. Other patients chose a single type of exer-
cise: indoor cycling (n = 3), outdoor cycling (n = 3), 
running/walking (n = 1) or swimming (n = 1). The 
majority (n = 19) of participants completed the full 
24-week exercise programme (range: 23–25 weeks).
Mean adherence was 79% (SD: 21%; range: 
39%–100%; i.e. 2.4 sessions per week). A total of 
16 patients (70%) completed ≥75% of the pre-
scribed training sessions and were classified as 
adherent although two dropped out before the six-
month assessment. Reasons for non-adherence 
were lack of time, tiredness and fear of epileptic 
seizures, ‘lack of self-discipline for home-based 
exercise’, lack of motivation due to divorce, and 
medical advice not to swim due to ear problems 
(patient not interested in alternative activities). 
On average, patients exercised 126 minutes per 
(active) week (range = 26–322 minutes). Average 
exercise intensity was 76% (range = 68%–87%) of 
maximum heart rate. Overall, exercise perfor-
mance was classified as excellent/good in 16 
patients (70%), adequate in 3 (13%) and inade-
quate in 4 (17%).
Four participants required additional assistance 
with using the heart rate monitor. These problems 
were resolved via consultation by telephone.
Safety and injury
After the baseline exercise test, one patient was 
excluded from further participation for safety reasons 
because of ECG deviations. The majority of exercise 
participants had (had) epileptic seizures (74%) and 
used anti-epileptic drugs (61%), but this did not 
complicate exercise adherence (see Online table). 
However, one patient, who had already experienced 
frequent seizures that continued during the exercise 
intervention, reported serious feelings of insecurity 
and doubts about her capability to continue the exer-
cise intervention. The physiotherapist and the patient 
together decided to decrease the frequency of training 
session from three to two sessions per week.
There were no exercise-induced injuries 
although one patient reported aggravation of pre-
existing osteoarthritis-related knee pain at the sixth 
month of the exercise programme. The physiother-
apists recommended reducing resistance during 
training and this decreased the pain symptoms.
Patient-reported satisfaction
Data on satisfaction were available for 20 patients. 
Of these, 16 patients (84%) evaluated the physical 
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Figure 1. Flow of participants through the trial (accrual and attrition).
NPA: neuropsychological assessment; CPET: cardiorespiratory exercise testing; ECG: electrocardiogram.
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exercise programme as good or excellent, and four 
as moderately/sufficiently satisfactory. The major-
ity evaluated the build-up, intensity and length of 
the exercise sessions as good (Table 2). A total of 
17 patients reported that they intended to continue 
their training after study completion although 9 of 
Table 1. Baseline sociodemographic, clinical and physical characteristics.
Characteristic Intervention group (N = 23) Control group (N = 11)
Age, years
 Mean (SD) 48.0 (9.4) 48.0 (11.9)
Female, N (%) 13 (56%) 6 (55%)
Education, N (%)
 Low 2 (9%) 0 (0%)
 Middle 10 (43%) 6 (55%)
 High 11 (48%) 5 (45%)
WHO tumour grade, N (%)
 Grade II 16 (70%) 6 (55%)
 Grade III 7 (30%) 5 (45%)
Tumour histology, N (%)
 Astrocytoma 8 (35%) 5 (46%)
 Oligodendroglioma 12 (52%) 5 (46%)
 Oligoastrocytoma 3 (13%) 1 (8%)
Disease duration, years
 Mean (SD) 7.6 (4.9) 8.5 (8.6)
Left hemisphere, N (%) 10 (43%) 4 (36%)
Surgery, N (%)
 No 0 1 (9%)
 Biopsy 4 (17%) 1 (9%)
 Resection 19 (83%) 9 (82%)
Chemotherapy, N (%) 9 (39%) 4 (36%)
Radiotherapy, N (%) 14 (61%) 5 (45%)
Epilepsy 17 (73.9%) 8 (72.7%)
Anti-epileptic drugs 14 (60.9%) 6 (54.5%)
VO2 peak absolute, mL/min
 Mean (SD) 2252.0 (728.0) 2181.5 (741.0)
VO2 peak relative, mL/kg/min
 Mean (SD) 26.5 (7.4) 25.9 (4.8)
VO2 peak classification, N (%)10
 Recreational (vs. sedentary) 4 (17%) 1 (9%)
Self-reported physical activity, MET min/week
 Median (25th; 75th percentile) 4399.5 (1468.0; 8640.0) 4583.5 (1838.0; 13,457.0)
Body weight, kg
 Mean (SD) 84.8 (11.2) 83.7 (22.2)
BMI, kg/m²
 Mean (SD) 27.3 (3.0) 27.3 (5.5)
Letter digit substitution task,14 number correct
 Mean (SD) 43.9 (11.5) 43.4 (10.0)
SF-36 Physical Component Scale,25,26 scale 0–100
 Mean (SD) 44.7 (8.2) 47.0 (7.8)
WHO: World Health Organization; MET: metabolic equivalent of task; BMI: body mass index; SF: short form.
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them intended to decrease the frequency to one or 
two training sessions per week.
Overall, the difficulty of the training aids 
appeared to be acceptable. The remotely super-
vised character of the programme, the contact with 
the physiotherapist by e-mail and the involvement 
of the physiotherapist were highly valued. 
However, three patients indicated that they would 
have preferred group training.
Some quotes of patients extracted from their 
e-mails to the physiotherapist are displayed in the 
Online Box.
Feasibility of neuropsychological and 
physical assessments
Administration of the neuropsychological tests at 
the patients’ home took about 100 minutes. 
Estimated time to complete the questionnaires was 
about 60 minutes. There were (logistical) problems 
with planning the baseline exercise test, explaining 
a large range of 6–75 days between these assess-
ments in some cases, although in 91% of patients, 
this interval was shorter than 50 days, with a 
median of 20 days.
At follow-up, one exercise group patient did 
not return questionnaires, whereas all control 
group patients returned completed questionnaires. 
Individual patient circumstances and logistical 
problems with the exercise test explained intervals 
ranging from −35 (exercise test preceding neu-
ropsychological assessment) to 62 days between 
follow-up neuropsychological and physical assess-
ments, although in 90% of patients this interval 
ranged from −6 to 18 days, with a median of 4 
days.
Objective physical outcomes and self-
reported physical activity
Table 3 shows the baseline, follow-up and change 
scores with respect to absolute and relative VO2 
peak, BMI and self-reported activity for both groups 
as well as between-group differences in these out-
comes. In short, after six months, mean absolute 
VO2 peak (the primary outcome in these analyses) 
in the exercise group improved 6.0% compared to 
baseline, and mean relative VO2 peak improved 
7.3%. There were substantial inter-individual dif-
ferences in absolute VO2 peak, with the largest 
improvement 26.4%, and the largest decline 18.1%. 
Two of the four patients with a decline had a sub-
stantially shorter intervention duration (see Online 
Table). The control group (N = 9) showed an aver-
age decline of 1.1% in absolute VO2 peak over time 
and no change in mean relative VO2 peak. However, 
three patients showed an absolute VO2 peak 
improvement (2.5%, 9.0% and 17%). Between-
group analyses at six months indicated that, after 
correction for baseline values, participants in the 
Table 2. Post-intervention ratings of physical exercise programme, training aids and home-based guidance.
Patient rating of difficulty/quantity (Too) Easy/little Just right (Too) Difficult/many
 Build-up of the programme 3 (15%) 14 (70%) 3 (15%)
 Number of exercises per week 0 (0%) 11 (55%) 9 (45%)
 Intensity of sessions 3 (15%) 15 (75%) 2 (10%)
 Session duration 3 (15%) 14 (70%) 3 (15%)
 Difficulty Polar website 1 (5%) 17 (85%) 2 (10%)
 Difficulty Polar heart rate watch 0 (0%) 17 (85%) 3 (15%)
Patient rating of quality Excellent/good Sufficient Insufficient/poor
 Choice of activities 13 (68%) 5 (26%) 1 (5%)
 Experience of individualized training 14 (74%) 4 (21%) 1 (5%)
 E-mail contact with physical therapist 16 (84%) 2 (11%) 1 (5%)
 Involvement of physical therapist 18 (95%) 1 (5%) 0 (0%)
 Final programme rating 16 (84%) 2 (11%) 1 (5%)
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exercise group had a higher aerobic fitness com-
pared to the control group (+158.9 mL/min; 95% 
CI: 44.8 to 362.5, and 2.0 mL/kg/min; 95% CI: −0.4 
to 4.4), with a small effect size (d = 0.24).
At baseline, 19 of 23 patients (83%) were clas-
sified as overweight, of whom 6 were obese. BMI 
decreased in the exercise group, but not in the con-
trol group, but there were no between-group differ-
ences in mean BMI at six months, after correction 
for baseline.
Self-reported physical activity varied widely 
among participants. The median self-reported 
physical activity increased in both groups, but 
more strongly in the exercise group. The average 
increase was 126% in the exercise group compared 
to 23% in the control group.
Discussion
The results of this pilot RCT provide support for 
the feasibility of a novel, remotely supervised, 
home-based aerobic exercise intervention for moti-
vated patients with stable grades II and III gliomas. 
However, accrual of patients to the study was lim-
ited. The results suggest a positive effect of the 
programme on physical fitness. There were no 
adverse events related to the programme.
Overall, adherence was good; on average, par-
ticipants in the exercise group adhered to 79% of the 
prescribed sessions (i.e. a mean of 2.4 sessions and 
an average training time of 126 minutes per week) 
and their experiences were positive although 45% 
reported that the frequency of the exercise sessions 
was (too) high. The programme included several 
features that are known to enhance treatment fidelity 
and enjoyment, and help overcome potential barri-
ers to exercise (such as travel distance, feelings of 
uncertainty, motivational problems or time con-
straints). First, patients could exercise at home. 
Second, patients received regular guidance from 
both technology (a commercially available heart 
rate watch) and a physiotherapist. Remote contact is 
recommended in the literature as a strategy to 
enhance adherence to online interventions.27–29 In 
previous studies of older adults, adherence to and 
effectiveness of blended care physical activity pro-
grammes were comparable to those observed in 
supervised onsite programmes. Third, patients were 
allowed, within certain limits, to choose their own 
activities. Current evidence suggests that exercise 
enjoyment is an important determinant of physical 
activity and exercise self-efficacy.30,31 These ele-
ments are aimed at implementation of regular exer-
cise in patients’ daily routines and may aid continuing 
to exercise after the intervention period had 
ended.29,32 In fact, 17 of 20 of our patients reported a 
willingness to continue the physical exercise pro-
gramme after the study period although nine 
intended to decrease their schedule to 1 or 2 training 
sessions per week. Two sessions per week may be 
sufficient to maintain some of the beneficial effects 
of exercise,33 but it is below the general exercise rec-
ommendation for cancer survivors.34
The high level of feasibility in terms of adher-
ence to the exercise programme observed among 
participants contrasted with the problems experi-
enced in recruiting patients into the study. Initially, 
our aim was to include 60 patients, but we were 
only able to recruit 34. In all, 47% of the 62 patients 
for whom a reason for declining participation was 
known indicated they lacked exercise motivation or 
time and probably considered this long and inten-
sive programme too much for them. This number 
may actually be larger, as it is likely that some of 
the patients who did not provide a reason for declin-
ing to participate or did not respond to the invitation 
had similar reasons. It is difficult to determine in a 
randomized setting the extent to which patients 
decline participation because of a lack of interest in 
the intervention being offered, not wanting to com-
plete questionnaires and tests, not wanting to be 
randomized or a combination of these factors. We 
would note that previous exercise studies in cancer 
patients also suffered from recruitment problems. 
In a meta-analysis of the effectiveness of exercise 
interventions for fatigue in cancer patients, only 10 
of the 26 studies that conducted a sample size calcu-
lation were successful in recruiting their target.35
Although three-quarters of the participants had 
(had) symptoms of epilepsy, this did not complicate 
exercise adherence, except for one patient with very 
frequent seizures, for whom the programme was 
adapted slightly. Previous studies have suggested 
that exercise in patients with epilepsy may result in 
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reduction of seizure susceptibility, improvement of 
quality of life, reduction of anxiety and depression, 
and better social integration.36
We also included outcome data on the intermedi-
ate (exercise) endpoint as a measure of feasibility of 
an exercise programme designed to improve cogni-
tive function through improvements in VO2 peak in 
this specific population. As changes in VO2 peak can 
be better understood in comparison to patients who 
did not exercise, we included the comparison for this 
outcome in our analyses. The preliminary results 
suggest that the programme could be effective in 
increasing physical fitness and, perhaps, decreasing 
(over)weight. Absolute VO2 peak, as determined 
with maximum exercise testing, of patients in the 
exercise group increased significantly, as compared 
to no change in the control group. Although the study 
was not powered for statistical analysis on group dif-
ferences in outcome, in this analysis a small but clini-
cally relevant effect37,38 on absolute VO2 peak (a 
difference of 158.9 mL/min) was observed, which 
was comparable to the within-group analyses.
Self-reported physical activity varied widely 
among participants. Both groups in our study 
reported an increase in physical activity although the 
increase was substantially larger in the exercise 
group. This suggests a certain level of study reactiv-
ity (i.e. that patients in the control group also changed 
their behaviour, simply because they were study par-
ticipants), which may have led to an underestimation 
of the observed intervention effects. This is a com-
mon problem in exercise oncology trials.39
Feasibility of administration of largely the same 
battery of neuropsychological tests and question-
naires that we used here was demonstrated in a pre-
vious large RCT21 in patients with stable glioma. In 
this study, patients experienced the exercise tests as 
more burdensome than the neuropsychological 
tests due to their physically challenging nature and 
because they had to travel.
An important limitation of our study is its small 
sample size. By allocation of participants in a 2:1 
ratio, we could make optimum use of the number of 
participants, as it allowed us to evaluate feasibility 
and potential (within-group) effects of the pro-
gramme in a larger group, but at the cost of limiting 
the precision of the between-group comparison.
In addition, as discussed above, uptake was low 
(25%), predominantly due to patients’ lack of time 
or motivation to participate in the trial and/or train-
ing programme. Overall, this resulted in a moti-
vated group of participants for whom an intensive 
exercise programme may be particularly feasible. 
This suggests that the intervention, in its current 
form, may be of interest to a smaller subset of the 
target population.
Furthermore, all patients were tested on a cycle 
ergometer because group allocation and preferred 
training modality were not known until after base-
line exercise testing. However, not everyone 
trained on a bicycle, and consequently both the 
baseline and follow-up tests lacked exercise speci-
ficity. This could have led to an underestimation of 
changes in aerobic fitness in patients who chose 
running or swimming as training modality.
Despite these limitations, the observed interven-
tion effect and its specific relationship with pro-
gramme adherence in this study warrant replication 
in a larger trial. The design of future exercise inter-
ventions and (randomized controlled) trials can 
hopefully benefit from the lessons we learned from 
this pilot study. First, we recommend to take the 
challenging recruitment in this patient group into 
account when allocating time for the recruitment 
phase of the study. Second, future trials could ben-
efit from using objective measures of physical 
activity (i.e. accelerometers) instead of relying on 
self-report measures, which are prone to overesti-
mation of physical activity levels.40,41 In line with 
the literature,42 we recommend the use of cardio-
pulmonary exercise testing for baseline testing in 
order to minimize risk of exercise-related adverse 
events (in this study, we excluded one patient at 
risk). This maximum exercise test is considered the 
gold standard for assessment of cardiorespiratory 
fitness because it provides the most accurate deter-
mination of peak oxygen uptake (VO2 peak).42 
Future trials might employ study logistics to enable 
adaptation of type of exercise test to training activi-
ties. The results can also be used in prescribing 
individual exercise programmes (and their reliable 
evaluation in case of additional follow-up exercise 
testing). Finally, studies offering a programme with 
a lower frequency of exercise activities per week 
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might be less likely to suffer from problems with 
uptake and may have a higher programme adher-
ence than our study. Although two sessions per 
week is below the general exercise recommenda-
tion for cancer survivors,34 patients with low physi-
cal fitness would likely still benefit from two 
sessions per week. During the programme, the 
training frequency could be increased for patients 
who are able and willing, thus providing even bet-
ter tailoring to individual needs and abilities.
The primary aim of our study was to investigate 
the feasibility of an aerobic exercise intervention 
for the improvement of cognitive function through 
improvement of aerobic fitness, as it has been sug-
gested that increased cardiorespiratory fitness (i.e. 
VO2 peak) may be associated with improvements 
in cognitive capacity.43,44 The preliminary results 
presented here suggest that this intensive exercise 
programme helped to improve cardiorespiratory 
fitness. A forthcoming evaluation of the study 
results will address the question whether our physi-
cal exercise programme also had an effect on cog-
nitive functioning in this patient population. This 
will include detailed investigation of the effects of 
the exercise programme on the domains of atten-
tion, memory and executive function, and on self-
reported cognitive symptoms, fatigue, sleep, mood 
and quality life.
Given the need for management of the multi-
tude of symptoms in this neuro-oncological patient 
group, and the potential applicability of exercise to 
aid in this management,2 the findings discussed 
here warrant further investigation of exercise inter-
ventions that may benefit this population.
Clinical messages
•• Six months of home-based, remotely 
coached exercise is feasible in a select 
group of motivated glioma patients.
•• Recruitment of the total group of stable 
patients to a long and intensive exercise 
intervention is difficult.
•• Exercise may improve cardiorespiratory 
fitness and physical functioning in neuro-
oncological patients.
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